0.9992
Schlusskurs vom Vortag:
$1.00
Offen:
$1
24-Stunden-Volumen:
945.32K
Relative Volume:
1.58
Marktkapitalisierung:
$125.14M
Einnahmen:
$397.99M
Nettoeinkommen (Verlust:
$-102.14M
KGV:
-1.281
EPS:
-0.78
Netto-Cashflow:
$8.70M
1W Leistung:
-4.38%
1M Leistung:
-24.30%
6M Leistung:
-38.70%
1J Leistung:
-71.93%
Beauty Health Company Stock (SKIN) Company Profile
Firmenname
Beauty Health Company
Sektor
Telefon
800-603-4996
Adresse
2165 SPRING STREET, LONG BEACH
Vergleichen Sie SKIN mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
SKIN
Beauty Health Company
|
0.9992 | 125.14M | 397.99M | -102.14M | 8.70M | -0.78 |
![]()
PG
Procter Gamble Co
|
168.47 | 395.04B | 84.35B | 15.48B | 15.47B | 6.28 |
![]()
UL
Unilever Plc Adr
|
62.15 | 149.31B | 65.10B | 6.16B | 0 | 2.4569 |
![]()
CL
Colgate Palmolive Co
|
94.26 | 76.72B | 20.10B | 2.89B | 3.55B | 3.52 |
![]()
KMB
Kimberly Clark Corp
|
141.47 | 46.92B | 20.06B | 2.55B | 2.51B | 7.55 |
![]()
KVUE
Kenvue Inc
|
22.91 | 43.96B | 15.46B | 1.03B | 1.34B | 0.53 |
Beauty Health Company Stock (SKIN) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2023-11-15 | Herabstufung | Jefferies | Buy → Hold |
2023-11-14 | Herabstufung | Canaccord Genuity | Buy → Hold |
2023-11-14 | Herabstufung | JP Morgan | Neutral → Underweight |
2023-11-14 | Herabstufung | Piper Sandler | Overweight → Underweight |
2023-11-14 | Herabstufung | Raymond James | Mkt Perform → Underperform |
2023-11-14 | Herabstufung | TD Cowen | Outperform → Market Perform |
2023-11-14 | Herabstufung | The Benchmark Company | Buy → Hold |
2023-11-14 | Herabstufung | William Blair | Outperform → Mkt Perform |
2023-08-25 | Fortgesetzt | Canaccord Genuity | Buy |
2023-06-21 | Herabstufung | Stifel | Buy → Hold |
2023-03-20 | Hochstufung | Exane BNP Paribas | Underperform → Neutral |
2022-11-09 | Herabstufung | JP Morgan | Overweight → Neutral |
2022-03-11 | Eingeleitet | JP Morgan | Overweight |
2022-01-07 | Eingeleitet | William Blair | Outperform |
2021-12-23 | Eingeleitet | Raymond James | Mkt Perform |
2021-10-08 | Eingeleitet | Stifel | Buy |
2021-10-04 | Eingeleitet | Cowen | Outperform |
2021-07-19 | Eingeleitet | Jefferies | Buy |
2021-07-01 | Eingeleitet | Goldman | Buy |
2021-06-28 | Bestätigt | The Benchmark Company | Buy |
2021-06-24 | Eingeleitet | Piper Sandler | Overweight |
2021-06-15 | Eingeleitet | Canaccord Genuity | Buy |
Alle ansehen
Beauty Health Company Aktie (SKIN) Neueste Nachrichten
DNA-coded skincare, wearable nanobots: The beauty products of tomorrow - Vogue Business
SHAREHOLDER ALERT: Levi & Korsinsky Reminds The Beauty Health Company Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 16, 2024SKIN - ACCESS Newswire
The Beauty Health Company (NASDAQ:SKIN) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny - simplywall.st
SKIN STOCKHOLDER ALERT: Kaskela Law LLC Announces - GlobeNewswire
The Vogue Business Beauty Trend Tracker - Vogue Business
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Shareholders of The Beauty Health Company(SKIN) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
Benchmark maintains Hold on Beauty Health amid 2025 guidance By Investing.com - Investing.com Australia
The Ultimate List of Beauty Industry Stats (2025) - Exploding Topics
Analysts Offer Insights on Consumer Cyclical Companies: Beauty Health (SKIN) and Tesla (TSLA) - The Globe and Mail
Benchmark maintains Hold on Beauty Health amid 2025 guidance - Investing.com
HydraFacial Treatment Market Is Booming Worldwide 2025-2032 | - openPR
Health & Beauty - Very
Unpacking Q4 Earnings: BeautyHealth (NASDAQ:SKIN) In The Context Of Other Personal Care Stocks - Yahoo Finance
Beauty Health (NASDAQ:SKIN) Price Target Lowered to $1.50 at Canaccord Genuity Group - MarketBeat
Beauty Health (NASDAQ:SKIN) Releases Quarterly Earnings Results, Beats Estimates By $0.02 EPS - MarketBeat
BeautyHealth (SKIN) Reports Q4: Everything You Need To Know Ahead Of Earnings - MSN
BeautyHealth’s Hydrafacial Opens New Beijing Experience Center, Signaling Continued Investment in High-Growth China Market - Business Wire
Ulta Beauty, Peloton Rally On 'Pivotal' Sentiment, Upgrade - Investor's Business Daily
Ulta Stock, Peloton Rally As Beauty, Health Play Defense - MSN
The Beauty Health Company (NASDAQ:SKIN) Analysts Just Cut Their EPS Forecasts Substantially - Simply Wall St
Beauty Health Co. Navigates Challenges in Earnings Call - TipRanks
Canaccord cuts Beauty Health stock target to $1.50, keeps Hold By Investing.com - Investing.com Canada
Why BeautyHealth (SKIN) Stock Is Trading Lower Today - Yahoo Finance
Stifel maintains Hold on Beauty Health, price target at $2.00 By Investing.com - Investing.com Canada
Cautious Hold on Beauty Health Amid Sales Guidance Shortfall and China Execution Risks - TipRanks
Stifel maintains Hold on Beauty Health, price target at $2.00 - Investing.com
The Beauty Health Company (NASDAQ:SKIN) Q4 2024 Earnings Call Transcript - Insider Monkey
Cautious Optimism Amidst Market Challenges: Beauty Health’s Hold Rating Explained - TipRanks
Canaccord cuts Beauty Health stock target to $1.50, keeps Hold - Investing.com
BeautyHealth Reports Full Year and Fourth Quarter 2024 Financial Results - The Manila Times
Beauty Health Co earnings beat by $0.03, revenue topped estimates - Investing.com South Africa
BeautyHealth Reports 2024 Financial Results Amid Challenges - TipRanks
Earnings call transcript: Beauty Health Co beats Q4 2024 EPS forecast - Investing.com Australia
Beauty Health (SKIN) Reports Q4 Earnings: What Key Metrics Have to Say - Yahoo Finance
Beauty Health Co SEC 10-K Report - TradingView
The Beauty Health Company (SKIN) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Beauty Health Q4 Net Loss Widens, Sales Decline; Sets Q1, 2025 Guidance -March 12, 2025 at 05:14 pm EDT - Marketscreener.com
Beauty Health Co reports results for the quarter ended December 31Earnings Summary - TradingView
Beauty Health Q4 revenue beats estimates, stock falls on weak guidance - Investing.com India
Beauty Health Q4 revenue beats estimates, stock falls on weak guidance By Investing.com - Investing.com South Africa
BeautyHealth (NASDAQ:SKIN) Beats Q4 Sales Targets But Full-Year Sales Guidance Misses Expectations Significantly - Financial Content
The Beauty Health Company Reports Strong Q4 2024 Financial Results with Improved Margins and Adjusted EBITDA - Nasdaq
Finanzdaten der Beauty Health Company-Aktie (SKIN)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):